MORGAN STANLEY PLC/CALL/CVS HEALTH/80/0.1/20.12.24 Share Price

Warrant

DE000MB33SY1

Real-time Bid/Ask 01:36:12 01/07/2024 pm IST
0.068 EUR / 0.079 EUR +7.25% Intraday chart for MORGAN STANLEY PLC/CALL/CVS HEALTH/80/0.1/20.12.24
Current month-5.48%
1 month+50.00%
Date Price Change
01/24/01 0.067 -2.90%
28/24/28 0.069 +13.11%
27/24/27 0.061 -20.78%
26/24/26 0.077 -4.94%
25/24/25 0.081 -12.90%

Delayed Quote Börse Stuttgart

Last update July 01, 2024 at 12:38 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying CVS HEALTH CORPORATION
Issuer Morgan Stanley
WKN MB33SY
ISINDE000MB33SY1
Date issued 01/02/2023
Strike 80 $
Maturity 20/12/2024 (173 Days)
Parity 10 : 1
Emission price 1.83
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.87
Lowest since issue 0.035
Spread 0.011
Spread %13.92%

Company Profile

CVS Health Corporation is one of the leading American suppliers of health products and services. Net sales (including intragroup) break down by activity as follows: - medical insurance plan management services (45.6%; Pharmacy Benefit Management): administrative management (reimbursement management, patient claim processing, etc.), drug distribution, decision-making information, sales of medical information management services, etc.; - retail distribution (28.5%): sale of prescription pharmaceutical products, OTC products, beauty and cosmetics products. At the end of 2023, products are marketed primarily via a network of more than 9,000 outlets and via the Internet. In addition, the group offers healthcare services through more than 1,000 clinics (MinuteClinic®); - medical benefits management (25.8%); - other (0.1%).
Sector
-
More about the company

Ratings for CVS Health Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: CVS Health Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
59.06 USD
Average target price
69.1 USD
Spread / Average Target
+16.99%
Consensus